Aug 2026· International Conference on Multimedia Analysis and Pattern Recognition· pp. 448-453· 0 citations· 19 references
Abstract
Alzheimer’s disease (AD) is a progressive neurode-generative disorder for which early and accurate diagnosis is critical for clinical management. Effective diagnosis depends on both disease staging and continuous cognitive monitoring through the Mini-Mental State Examination (MMSE), yet most existing deep learning-based methods predict these two targets with separate models, and the few joint multi-task approaches struggle to balance classification and regression during training. To overcome these limitations, we propose CFML, a multitask architecture that integrates 3D MRI and demographic metadata through cross-modal fusion and attention-based feature gating, producing task-tailored representations for joint AD stage classification and MMSE regression. Within CFML, we introduce the T-Hybrid Loss, a dual-branch adaptive task-weighting strategy that fuses loss-aware and gradient-aware signals through a dispersion-driven coefficient, simultaneously correcting cross-task scale mismatch and gradient dominance. Comprehensive evaluations on ADNI-1, ADNI-2, and AIBL show that CFML achieves 97.32% accuracy with 1.43 (RMSE) MMSE on ADNI-1 and 97.35% accuracy with 1.45 (RMSE) MMSE in the combined three-class AD/CN/MCI setting, outperforming recent single-task and multi-task baselines.
The proposed GBP-SCMF provides an effective and interpretable multimodal strategy for computer-aided AD diagnosis and integrates three complementary mechanisms: generative brain-prior enhancement to inject disease-related pathological knowledge into imaging representations, self-regulated multimodal alignment to reduce...
Yi-Bo Huang, Xiao-Long Guo, Zhiyi Li et al.· Journal of imaging informati...· 0 citations
A multimodal deep learning classification framework integrating structural magnetic resonance imaging (sMRI) and clinical features and an adaptive gated fusion module that dynamically integrates concatenated global multimodal features with cross-modal interaction features is proposed.
Xiao-Li Yang, Chen-Chen Wang, Xiao Li et al.· Biomedical engineering and p...· 0 citations
Overall, current AI systems remain highly dependent on existing datasets and heterogeneous evaluation protocols, which limit generalizability and clinical applicability, and future research should prioritize representative multimodal datasets, rigorous external validation, and clinically interpretable AI systems.
José Menezes, M. I. Barbosa, P. M. Rodrigues· Italian National Conference...· 0 citations
Early and accurate classification of Alzheimer's disease (AD) stages from magnetic resonance imaging (MRI) remains a critical challenge in clinical neuroimaging, particularly for distinguishing early-stage cognitive decline from normal aging. Existing deep learning approaches applied to publicly available augmented MRI...
NeuroFusion achieves state-of-the-art brain age prediction on the OpenBHB benchmark and maintains strong performance with only 5 labelled examples, demonstrating clinically relevant generalizatio in few-shot adaptation to unseen sites.
Molla Md Rony, Rahman Md Takibur, Md. Emran Hossain Dipu et al.· International Journal of Adv...· 0 citations
A key aspect of diagnosing Alzheimer’s disease (AD) is identifying mild cognitive impairment (MCI), a sensitive transitional stage between normal cognition (NC) and AD. We divided AD disease progression into three stages: NC, MCI, and AD according to severity. We used CoopLearning to integrate multi-view medical da...
Yan-Hong Luo, Nan Dai, Yu Qiao et al.· Frontiers in Aging Neuroscie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.